Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD101 expression by Langerhans cell histiocytosis cells.

A Bouloc1, M L Boulland, F Geissmann

  • 1Department of Dermatology; INSERM U448; Department of Pathology, Hôpital Henri-Mondor, Créteil, France. bouloc@univ-paris12.fr

Histopathology
|February 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro effects of wound-dressings on key wound healing properties of dermal fibroblasts.

Experimental dermatology·2024
Same author

The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort.

The British journal of dermatology·2020
Same author

The role of exposome in acne: results from an international patient survey.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker.

The British journal of dermatology·2019
Same author

Author Correction: Yolk sac macrophage progenitors traffic to the embryo during defined stages of development.

Nature communications·2018
Same author

Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016.

Annales de dermatologie et de venereologie·2018

CD101 expression may aid in diagnosing Langerhans cell histiocytosis (LCH). While useful with other markers, its application is limited to frozen sections, unlike CD1a. Further research is needed.

Area of Science:

  • Immunology
  • Oncology
  • Dermatology

Background:

  • Langerhans cell histiocytosis (LCH) is a rare disorder characterized by the abnormal proliferation of Langerhans cells.
  • CD101 is a cell surface molecule expressed on dendritic cells, including Langerhans cells.

Purpose of the Study:

  • To investigate CD101 expression in LCH patients.
  • To evaluate CD101 as a diagnostic marker for LCH, potentially in conjunction with CD1a and S100 protein.
  • To assess if CD101 expression predicts disease evolution and dissemination.

Main Methods:

  • Immunohistochemical analysis of CD101 expression was performed on frozen tissue sections from 11 LCH cases.
  • Comparison of CD101 expression with established LCH markers (CD1a, S100 protein) was considered.

Related Experiment Videos

Main Results:

  • CD101 expression was detected in 9 out of 11 LCH cases (7 positive, high in 6; low in 3).
  • Two cases showed no CD101 expression.
  • No significant correlation was found between CD101 expression and disease evolution, localization, or dissemination.

Conclusions:

  • CD101 represents a potential new phenotypic marker for LCH diagnosis when used with other markers.
  • The utility of CD101 is currently limited by the requirement for frozen sections, unlike the CD1a antibody.